etoposide has been researched along with Neoplasm Metastasis, Unknown Primary in 44 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 18 (40.91) | 18.2507 |
2000's | 17 (38.64) | 29.6817 |
2010's | 8 (18.18) | 24.3611 |
2020's | 1 (2.27) | 2.80 |
Authors | Studies |
---|---|
Afchain, P; Baudin, E; Desgrippes, R; Hadoux, J; Hautefeuille, V; Lepage, C; Lorgis, V; Monterymard, C; Scoazec, JY; Thuillier, F; Tougeron, D; Walter, T | 1 |
Allinson, K; Candy, N; Carr, O; McMillen, J; Trivedi, R; Young, A | 1 |
Barbera, MA; Biasco, G; Bondi, A; Brandi, G; Brighi, N; Campana, D; Corbelli, J; Pantaleo, MA; Paragona, M | 1 |
Abe, H; Hashimoto, T; Kato, T; Mizukami, T; Ohata, T; Takahashi, T | 1 |
Ishihara, M; Katayama, N; Mizuno, T; Oda, H; Okano, M; Saito, K; Tamaru, S; Yamashita, Y | 1 |
Hamano, Y; Hyodo, I; Moriwaki, T; Sakashita, S; To, K; Watahiki, T; Yamada, T | 1 |
Chohnabayashi, N; Ishikawa, G; Jinta, T; Kitamura, A; Mochizuki, S; Nishimura, N; Suzuki, K; Tomishima, Y; Yamano, Y | 1 |
Dray, M; Mweempwa, A; Tan, A | 1 |
Chao, TK; Hou, WC; Kao, CC; Lai, YJ; Li, HM; Su, HY; Yu, MH | 1 |
Azad, A; Chionh, F; Lee, C | 1 |
Druck, P; Gupta, P; Iwamoto, C; Mesa, H; Niehans, GA; Rawal, A; Rezcallah, A | 1 |
Krüger, I; Lindenfelser, R; Scherwitz, P | 1 |
Abad, A; Balaña, C; Cirauqui, B; Font, A; Manzano, JL; Mate, JL; Moreno, I; Rosell, R | 1 |
Barceló, R; Ferreiro, J; Fuente, N; López Vivanco, G; Muñoz, A; Rubio, I | 1 |
Cardarelli, N; Carle, F; Cellerino, R; Cetto, GL; Contu, A; D'Aprile, M; Fedeli, SL; Fiorentini, G; Gesuita, R; Giorgi, F; Montironi, R; Nortilli, R; Parziale, AP; Piga, A | 1 |
Burris, HA; Erland, JB; Greco, FA; Hainsworth, JD; Hermann, R; Litchy, S; Morrissey, LH; Rodriguez, GI; Shaffer, DW; Yardley, DA | 1 |
Cardillo, F; Carle, F; Catalano, V; Cellerino, R; Cetto, G; Gesuita, R; Giorgi, F; Montironi, R; Nortilli, R; Piga, A; Porfiri, E; Riva, N | 1 |
Alberts, SR; Erlichman, C; Furth, A; Lathia, CD; Molina, JR; Reid, JM; Safgren, SL; Sloan, JA | 1 |
De Braud, F; Di Meglio, G; Fazio, N; Grana, C; Lorizzo, K; Pelosi, G; Torrisi, R; Tradati, N | 1 |
Chiba, N; Gamoh, M; Ishioka, C; Kakudo, Y; Kato, S; Murakawa, Y; Nishino, Y; Ohori, H; Ohtsuka, K; Sakayori, M; Shibata, H; Shimodaira, H; Suzuki, T; Takahashi, M; Takahashi, S; Yamaura, G; Yasuda, K; Yoshioka, T | 1 |
Hop, WC; Planting, AS; Stoter, G; van der Gaast, A; Verweij, J | 1 |
Bosl, GJ; Chaganti, RS; Mazumdar, M; Motzer, RJ; Reuter, VE; Rodriguez, E | 1 |
Henzen-Logmans, SC; Planting, AS; Stoter, G; van der Gaast, A; Verweij, J | 1 |
de Campos, ES; Harris, M; Menasce, LP; Radford, J; Thatcher, N | 1 |
Chen, YM; Kuo, BI; Liu, JM; Perng, RP; Tsai, CM; Wang, SY; Whang-Peng, J | 1 |
Erland, JB; Greco, FA; Hainsworth, JD; Kalman, LA; Schreeder, MT | 1 |
Greco, FA; Hainsworth, JD | 3 |
Amano, T; Hatori, S; Imada, T; Ito, H; Kondo, J; Maehara, T; Rino, Y; Shiozawa, M; Suzuki, Y; Takahashi, M | 1 |
Chang, J; Chow, W; Correia, J; Dancey, J; Dulude, H; Franssen, E; Gallant, G; Girouard, M; Goel, R; Verma, S; Warner, E | 1 |
Chao, Y; Chen, LT; Chen, YM; Chiou, TC; Hsieh, RK; Liu, JM; Liu, SM; Tiu, CM; Whang-Peng, J; Wu, HW | 1 |
de Mulder, PH; de Wit, R; Louwerens, M; Rodenhuis, S; Schornagel, J; Verweij, J | 1 |
Burris, HA; Erland, JB; Gray, JR; Greco, FA; Hainsworth, JD; Kalman, LA; Schreeder, MT | 1 |
Dowell, JE; Garrett, AM; Hande, KR; Johnson, DH; Shyr, Y | 1 |
Lasset, C; Merrouche, Y; Negrier, S; Peaud, PY; Rebattu, P; Trillet-Lenoir, V; Voog, E | 1 |
Borel, C; Ducreux, M; Fizazi, K; Le Chevalier, T; Ruffié, P; Saghatchian, M; Théodore, C | 1 |
Culine, S; Cupissol, D; Fabbro, M; Pinguet, F; Romieu, G; Ychou, M | 1 |
Greco, FA; Hainsworth, JD; Johnson, DH | 3 |
Prins, E; Splinter, TA; Van Der Gaast, A; Verwey, J | 1 |
Henzen-Logmans, SC; Rodenburg, CJ; Stoter, G; van der Gaast, A; Verweij, J | 1 |
Abbruzzese, JL; Faintuch, J; Frost, P; Raber, MN; Sumrall, C | 1 |
2 review(s) available for etoposide and Neoplasm Metastasis, Unknown Primary
Article | Year |
---|---|
The evolving role of paclitaxel for patients with carcinoma of unknown primary site.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Clinical Trials as Topic; Etoposide; Humans; Neoplasms, Unknown Primary; Paclitaxel | 1999 |
The role of etoposide in the treatment of poorly differentiated carcinoma of unknown primary site.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Etoposide; Humans; Neoplasms, Unknown Primary | 1991 |
19 trial(s) available for etoposide and Neoplasm Metastasis, Unknown Primary
Article | Year |
---|---|
FOLFIRINEC: a randomized phase II trial of mFOLFIRINOX vs platinum-etoposide for metastatic neuroendocrine carcinoma of gastroenteropancreatic or unknown origin.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Carcinoma, Neuroendocrine; Etoposide; Female; Fluorouracil; Humans; Intestinal Neoplasms; Irinotecan; Leucovorin; Male; Neoplasm Metastasis; Neoplasms, Unknown Primary; Neuroendocrine Tumors; Oxaliplatin; Pancreatic Neoplasms; Platinum Compounds; Progression-Free Survival; Prospective Studies; Quality of Life; Stomach Neoplasms; Survival Rate; Treatment Outcome | 2021 |
A phase II study of cisplatin, etoposide and gemcitabine in an unfavourable group of patients with carcinoma of unknown primary site.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Deoxycytidine; Etoposide; Female; Gemcitabine; Humans; Male; Middle Aged; Neoplasms, Unknown Primary | 2003 |
[Prognostic and predictive factors of patients with cancer of unknown origin treated with a paclitaxel-based chemotherapy].
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Paclitaxel; Predictive Value of Tests; Prognosis; Survival Rate | 2004 |
Carboplatin, doxorubicin and etoposide in the treatment of tumours of unknown primary site.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Doxorubicin; Etoposide; Female; Humans; Infusions, Intravenous; Leukopenia; Male; Middle Aged; Neoplasms, Unknown Primary; Treatment Outcome | 2004 |
Carcinoma of unknown primary site: sequential treatment with paclitaxel/carboplatin/etoposide and gemcitabine/irinotecan: a Minnie Pearl Cancer Research Network phase II trial.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma; Deoxycytidine; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Gemcitabine; Humans; Irinotecan; Male; Middle Aged; Neoplasms, Unknown Primary; Paclitaxel; Treatment Outcome | 2004 |
Identification of clinical prognostic factors in patients with unknown primary tumors treated with a platinum-based combination.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Doxorubicin; Etoposide; Female; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasms, Unknown Primary; Patient Selection; Prognosis; Prospective Studies; Survival Analysis; Treatment Outcome | 2005 |
A phase I and pharmacokinetic study of the selective, non-peptidic inhibitor of matrix metalloproteinase BAY 12-9566 in combination with etoposide and carboplatin.
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Biphenyl Compounds; Carboplatin; Cohort Studies; Colonic Neoplasms; Enzyme Inhibitors; Etoposide; Female; Humans; Male; Matrix Metalloproteinase Inhibitors; Melanoma; Middle Aged; Neoplasms; Neoplasms, Unknown Primary; Neutropenia; Organic Chemicals; Phenylbutyrates; Thrombocytopenia; Thymoma; Treatment Outcome; Vomiting | 2005 |
Simple prognostic model to predict survival in patients with undifferentiated carcinoma of unknown primary site.
Topics: Adenocarcinoma; Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma; Cisplatin; Etoposide; Female; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Prognosis; Remission Induction | 1995 |
Phase II study of oral administration of etoposide for patients with well- and moderately-differentiated adenocarcinomas of unknown primary site.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Etoposide; Female; Humans; Male; Middle Aged; Neoplasms, Unknown Primary | 1993 |
Metastatic carcinoma of uncertain primary site: a retrospective review of 57 patients treated with vincristine, doxorubicin, cyclophosphamide (VAC) or VAC alternating with cisplatin and etoposide (VAC/PE).
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Cyclophosphamide; Dactinomycin; Drug Administration Schedule; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasms, Unknown Primary; Retrospective Studies; Vincristine | 1994 |
Carcinoma of unknown primary site: treatment with 1-hour paclitaxel, carboplatin, and extended-schedule etoposide.
Topics: Actuarial Analysis; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Etoposide; Female; Humans; Liver Neoplasms; Male; Mediastinal Neoplasms; Middle Aged; Neoplasms, Unknown Primary; Paclitaxel; Survival Analysis | 1997 |
One-hour paclitaxel, carboplatin, and extended-schedule etoposide in the treatment of carcinoma of unknown primary site.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Etoposide; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms, Unknown Primary; Paclitaxel; Survival Rate; Treatment Outcome | 1997 |
A multicentre phase II study of carboplatin and prolonged oral etoposide in the treatment of cancer of unknown primary site (CUPS).
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Humans; Male; Middle Aged; Neoplasms, Unknown Primary | 1998 |
Management of intermediate-prognosis germ-cell cancer: results of a phase I/II study of Taxol-BEP.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma; Cisplatin; Etoposide; Germinoma; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms, Unknown Primary; Paclitaxel; Prognosis; Testicular Neoplasms | 1999 |
A randomized Phase II trial in patients with carcinoma of an unknown primary site.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Etoposide; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Paclitaxel; Treatment Outcome | 2001 |
Multicentric phase II study of cisplatin and etoposide in patients with metastatic carcinoma of unknown primary.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Etoposide; Female; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Survival Analysis | 2000 |
Carcinoma of an unknown primary site: a chemotherapy strategy based on histological differentiation--results of a prospective study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Differentiation; Cisplatin; Etoposide; Female; Fluorouracil; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Interferon-alpha; Male; Middle Aged; Neoplasms, Unknown Primary; Prospective Studies | 2001 |
Alternative bimonthly cycles of doxorubicin, cyclophosphamide, and etoposide, cisplatin with hematopoietic growth factor support in patients with carcinoma of unknown primary site.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms, Unknown Primary; Prospective Studies; Treatment Outcome | 2002 |
Continuous infusion 5-fluorouracil, etoposide and cis-diamminedichloroplatinum in patients with metastatic carcinoma of unknown primary origin.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carcinoma, Squamous Cell; Cisplatin; Drug Evaluation; Etoposide; Fluorouracil; Humans; Middle Aged; Neoplasms, Unknown Primary; Remission Induction; Survival Rate | 1991 |
23 other study(ies) available for etoposide and Neoplasm Metastasis, Unknown Primary
Article | Year |
---|---|
Metastatic Neuroendocrine Carcinoma of Unknown Origin Arising in the Femoral Nerve Sheath.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Carcinoma, Neuroendocrine; Chemotherapy, Adjuvant; Etoposide; Female; Femoral Nerve; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Unknown Primary; Nerve Sheath Neoplasms; Palliative Care; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2017 |
Good performance of platinum-based chemotherapy for high-grade gastroenteropancreatic and unknown primary neuroendocrine neoplasms.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Cisplatin; Disease-Free Survival; Etoposide; Female; Humans; Intestinal Neoplasms; Male; Middle Aged; Neoplasms, Unknown Primary; Pancreatic Neoplasms; Retrospective Studies; Stomach Neoplasms | 2018 |
[A Case of Biopsy Confirmed Unresectable Retroperitoneal Seminoma Successfully Treated with Chemotherapy].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Cisplatin; Etoposide; Humans; Male; Neoplasms, Unknown Primary; Retroperitoneal Neoplasms; Seminoma | 2017 |
[A Case of Poorly Differentiated Carcinoma of Unknown Primary Site with Risk of Choriocarcinoma Syndrome Effectively Treated with Reduced Bleomycin,Cisplatin ,Etoposide Combination Regimen(BEP Regimen)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Choriocarcinoma; Cisplatin; Etoposide; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Risk Factors | 2018 |
A Neuroendocrine Tumor of Unknown Primary Origin that Responded to Treatment Based on Tumor Grade Progression.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carcinoma, Neuroendocrine; Cisplatin; Etoposide; Hormones; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasms, Unknown Primary; Neuroendocrine Tumors; Somatostatin; Treatment Outcome | 2019 |
Long-term survival of a patient with extensive small cell carcinoma of unknown primary etiology complicated by nephrotic syndrome.
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Cranial Irradiation; Edema; Etoposide; Glomerulonephritis, Membranous; Humans; Irinotecan; Lymphatic Metastasis; Neoplasms, Unknown Primary; Nephrotic Syndrome; Paraneoplastic Syndromes; Pleural Effusion, Malignant; Proteinuria; Radiotherapy, Adjuvant; Remission Induction; Tomography, X-Ray Computed | 2014 |
Recurrent Merkel cell carcinoma of the testis with unknown primary site: a case report.
Topics: Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Merkel Cell; Chemotherapy, Adjuvant; Etoposide; Humans; Male; Neoplasm Recurrence, Local; Neoplasms, Unknown Primary; Orchiectomy; Testicular Neoplasms; Treatment Outcome | 2016 |
Gestational choriocarcinoma with renal and pulmonary metastases lacking a primary uterine origin.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Cyclophosphamide; Dactinomycin; Etoposide; Female; Hematuria; Humans; Kidney Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Methotrexate; Neoplasms, Unknown Primary; Pregnancy; Vincristine | 2016 |
Small cell carcinoma of unknown primary presenting with disease confined to the central nervous system.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Central Nervous System Neoplasms; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Radiography; Radiotherapy Dosage | 2009 |
"Burned out" testicular seminoma presenting as a primary gastric malignancy.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Diagnosis, Differential; Etoposide; Gastrectomy; Gastroscopy; Humans; Ifosfamide; Immunohistochemistry; Male; Middle Aged; Neoplasms, Unknown Primary; Orchiectomy; Positron-Emission Tomography; Seminoma; Stomach Neoplasms; Testicular Neoplasms; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography | 2009 |
[Localization of primary small cell carcinoma with liver metastasis: a rare combination of colonic adenocarcinoma and undifferentiated small cell carcinoma].
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Colectomy; Colon; Colonic Neoplasms; Docetaxel; Doxorubicin; Etoposide; Female; Humans; Immunohistochemistry; Liver; Liver Neoplasms; Neoplasms, Multiple Primary; Neoplasms, Unknown Primary; Paclitaxel; Taxoids; Time Factors; Vincristine | 2002 |
Successful chemotherapy and 90Y-DOTATOC in a patient with mediastinal highly aggressive neuroendocrine carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Disease Progression; Etoposide; Female; Humans; Mediastinal Neoplasms; Middle Aged; Neoplasms, Unknown Primary; Octreotide; Remission Induction; Risk Factors; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2006 |
[Clinical characteristics of cancer of unknown primary (CUP)--a summary of 22 cases].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Female; Fluorouracil; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Unknown Primary; Paclitaxel; Prognosis; Survival Rate | 2007 |
Molecular and cytogenetic studies in the diagnosis of patients with poorly differentiated carcinomas of unknown primary site.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Blotting, Southern; Carcinoma; Chromosome Aberrations; Chromosome Disorders; Cisplatin; Etoposide; Female; Germinoma; Humans; Ifosfamide; In Situ Hybridization, Fluorescence; Karyotyping; Lymphoma; Male; Mediastinal Neoplasms; Middle Aged; Neoplasms, Unknown Primary; Neuroectodermal Tumors, Primitive, Peripheral; Prospective Studies; Retroperitoneal Neoplasms; Testicular Neoplasms; Treatment Outcome | 1995 |
Serum cytokine level fluctuations in chemotherapy-induced myelosuppression.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bone Marrow; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Fluorouracil; Granulocyte Colony-Stimulating Factor; Humans; Interleukin-1; Interleukin-3; Interleukin-6; Lung Neoplasms; Male; Middle Aged; Neoplasms, Unknown Primary; Stem Cell Factor | 1996 |
A case of malignant peritoneal mesothelioma showed complete remission with chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Caffeine; Cisplatin; Combined Modality Therapy; Drug Combinations; Etoposide; Female; Humans; Mesothelioma; Neoplasms, Unknown Primary; Peritoneal Neoplasms; Remission Induction; Tegafur; Uracil | 1998 |
Continuous infusion cisplatin and etoposide chemotherapy for cancer of unknown primary site (CUPS) in Taiwan, a region with a high prevalence of endemic viral infections.
Topics: Adult; Aged; Aged, 80 and over; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carrier State; Cisplatin; Drug Administration Schedule; Etoposide; Female; Hepatitis B; Hepatitis C; Humans; Infusions, Intravenous; Leukopenia; Male; Middle Aged; Neoplasms, Unknown Primary; Taiwan; Thrombocytopenia; Virus Diseases | 1998 |
Management of patients with cancer of unknown primary site.
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Carboplatin; Carcinoma; Etoposide; Evaluation Studies as Topic; Female; Humans; Male; Neoplasms, Unknown Primary; Paclitaxel; Prognosis; Survival Rate; Taxoids | 2000 |
Carcinoma of unknown primary site.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Clinical Trials, Phase II as Topic; Etoposide; Fatigue; Female; Follow-Up Studies; Humans; Leukopenia; Male; Middle Aged; Nausea; Neoplasms, Unknown Primary; Paclitaxel; Survival Analysis; Thrombocytopenia; Time Factors; Treatment Outcome; Vomiting | 2000 |
The role of cisplatin/bleomycin-based chemotherapy in the treatment of poorly differentiated carcinoma of unknown primary site.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma; Cisplatin; Clinical Protocols; Etoposide; Female; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Neoplasms, Unknown Primary; Remission Induction; Salvage Therapy; Survival Rate; Vinblastine | 1992 |
Etoposide/cisplatin-based chemotherapy for patients with metastatic poorly differentiated carcinoma of unknown primary site.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Etoposide; Female; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Remission Induction | 1992 |
Chemotherapy as treatment of choice in extrapulmonary undifferentiated small cell carcinomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Digestive System Neoplasms; Doxorubicin; Etoposide; Female; Genital Neoplasms, Female; Humans; Male; Middle Aged; Mitomycins; Neoplasm Staging; Neoplasms, Unknown Primary; Vincristine | 1990 |
Carcinoma of unknown primary: identification of a treatable subset?
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma; Cisplatin; Etoposide; Female; Humans; Male; Middle Aged; Neoplasms, Unknown Primary | 1990 |